Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins

Abstract T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatment for high-risk patients. Unlike acute myeloid le...

Full description

Bibliographic Details

Published in:	Blood Cancer Journal
Main Authors:	Thomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, Aurore Touzart, Mathieu Simonin, Johanna Mondesir, Ludovic Lhermitte, Jonathan Bond, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Marie Balsat, Norbert Vey, Elizabeth Macintyre, Norbert Ifrah, Hervé Dombret, Arnaud Petit, André Baruchel, Philippe Ruminy, Nicolas Boissel, Vahid Asnafi
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-01-01
Online Access:	https://doi.org/10.1038/s41408-022-00613-9